SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

A Comparison of Machine Learning Models for Classification of Parkinson's Disease During a Working Memory and Sustained Attention Task.

Brain Sci · 2026-07-24

DOI: 10.3390/brainsci16080781PMID: 42651093

Open accessresearch-article; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Background and objectivesIndividuals with Parkinson's disease (PD) experience deficits in working memory (WM) and sustained attention (ATTN), but diagnosing and monitoring these deficits remains challenging. This study compares machine learning (ML) classification models trained on EEG and pupillometry data from WM and ATTN tasks to identify task-specific and shared cognitive biomarkers of PD.MethodsEEG and pupillometry were recorded from PD patients and healthy controls (HC) during a visual change detection WM task and a continuous performance ATTN task. A standardized toolbox extracted 108 features, reduced via PCA and recursive elimination (RE) and classified using an SVM-RBF within a nested, 5-fold cross-validated pipeline, with class balancing (SMOTE) and feature selection performed strictly within training folds to prevent leakage.ResultsOn internal test folds, WM achieved 71% accuracy (F1 = 0.701) and ATTN achieved 73% (F1 = 0.699); on an independent hold-out set, WM achieved 63% accuracy (F1 = 0.626) and ATTN achieved 70% (F1 = 0.623). ATTN showed higher accuracy and precision, WM showed higher recall, and univariate analyses independently supported several top-ranked features (e.g., theta/beta and alpha/theta ratios); PAI and FAA, though top features in both tasks, reached univariate significance only in ATTN. These results indicate WM and ATTN yield complementary, task-linked neurophysiological signatures relevant to PD classification.ConclusionAt its current stage, this pipeline functions as a research tool for biomarker discovery rather than a clinical diagnostic, though larger, externally validated samples could support future screening and monitoring applications.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.